Volume 91, issue 10, Octobre 2004

Éditorial

La régulation des gènes de A à Z pour le prix Lasker et le prix Nobel de chimie 2004 (p.743)
Philippe Jeanteur

Brève

Rb et instabilité chromosomique (p.744-6)
Gilles L’Allemain

Synthèse

Molecular mechanisms involved in hormone resistance of prostate cancer (p.747-57)
Aurélie Cabrespine, Laurent Guy, Philippe Chollet, Éric Debiton, Jacques-Olivier Bay

Article original

Anticancer drugs off label used of: what do the experts think about? (p.769-77)
Isabelle Debrix, Thierry André, Annie Becker, Jean-Pierre Lotz, Joseph Gligorov, Yasmine Boukari, Bernard Milleron, Françoise Pene, Antoine Flahault

Effects of treatments on serum vitamin E levels in lung cancer (p.779-84)
Leïla Trabelsi Alouane, Chekib Ghawar, Fatma Tritar Cherif, Dalenda Belhabib, Mohsen Maalej

Prevention practices and cancer screening among general practitioners in Picardy (France) (p.785-91)
Olivier Ganry, Thomas Boche

Methodological and ethical quality in phase III cancer trials: role of the cooperative group (p.793-8)
Jean-Jacques Tuech, Patrick Pessaux, Grégoire Moutel, Véronique Thoma, Simon Schraub, Christian Hervé

Organization and impact of the multidisciplinary commitee in oncology (p.799-804)
Patrick Castel, Jean-Yves Blay, Pierre Meeus, Marie-Pierre Sunyach, Dominique Ranchère-Vince, Philippe Thiesse, Christophe Bergeron, Perrine Marec-Bérard, Antoine Lurkin, Isabelle Ray-Coquard

Tribune libre

Breaking “bad news” in oncology (p.805-7)
Bernard Hœrni

SOR

Clinical practice guideline: 2003 Update of Standards, Options et Recommendations for first line palliative chemotherapy in patients with metastatic colorectal cancer (summary report) (p.759-68)
Groupe de travail : Comité de rédaction : Thierry CONROY, Guillaume GORY-DELABAERE, Antoine ADENIS, Lise BOSQUET, Olivier BOUCHé, Christophe LOUVET, Emmanuel MITRY, Comité associé : Yves BéCOUARN, Jean-François BOSSET, Michel DUCREUX, Pierre-Luc ETIENNE, Yacine MERROUCHE, Geneviève MONGES, Philippe ROUGIER

Electronic journal of oncology

4-years results of weekly trastuzumab and paclitaxel in the treatment of women with HER2/neu overexpressing advanced breast cancer: single institution prospective study (p.10279-83)
Filip Janku, Olga Pribylova, Martina Zimovjanova, Gabriela Pazdrova, Martin Safanda, Milad Zemanova, Lubos Petruzelka